WallStreetZenWallStreetZen

NASDAQ: BNOX
Bionomics Limited Stock

$0.92-0.04 (-4.17%)
Updated Apr 23, 2024
BNOX Price
$0.92
Fair Value Price
$0.74
Market Cap
$10.66M
52 Week Low
$0.87
52 Week High
$6.41
P/E
0.03x
P/B
0.56x
P/S
815.06x
PEG
0x
Dividend Yield
N/A
Revenue
$14.50k
Earnings
-$21.09M
Gross Margin
100%
Operating Margin
-140,487.81%
Profit Margin
-140,642.5%
Debt to Equity
0.34
Operating Cash Flow
-$18M
Beta
0.38
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

BNOX Overview

Bionomics Ltd is a clinical-stage biopharmaceutical company focused on drug candidates to transform the lives of patients suffering from serious central nervous system disorders. The company's lead candidate, BNC210, is a treatment for Social Anxiety Disorder and Post-Traumatic Stress Disorder. Bionomics was incorporated in 1996 and is based in Eastwood, Australia.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BNOX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BNOX ($0.92) is overvalued by 24.7% relative to our estimate of its Fair Value price of $0.74 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
BNOX ($0.92) is not significantly undervalued (24.7%) relative to our estimate of its Fair Value price of $0.74 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
BNOX ($0.92) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more BNOX due diligence checks available for Premium users.

Be the first to know about important BNOX news, forecast changes, insider trades & much more!

BNOX News

Valuation

BNOX fair value

Fair Value of BNOX stock based on Discounted Cash Flow (DCF)
Price
$0.92
Fair Value
$0.74
Overvalued by
24.30%
BNOX ($0.92) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
BNOX ($0.92) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
BNOX ($0.92) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

BNOX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
0.03x
Industry
16.46x
Market
41.92x
BNOX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
BNOX is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

BNOX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.56x
Industry
5.93x
BNOX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

BNOX price to earnings growth (PEG)

For valuing profitable companies with growth potential
BNOX is good value based... subscribe to Premium to read more.
PEG Value Valuation

BNOX's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
BNOX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
BNOX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$26.4M
Liabilities
$6.7M
Debt to equity
0.34
BNOX's short-term assets ($11.09M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BNOX's short-term assets ($11.09M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BNOX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
BNOX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

BNOX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
BNOX$10.66M-3.85%0.03x0.56x
ERNA$10.60M-8.41%-0.48x4.75x
GRTX$10.55M+1.57%-0.15x-0.08x
KZIA$10.41M+4.77%-1.08x3.00x
ELAB$10.40M+3.45%-1.50x2.72x

Bionomics Limited Stock FAQ

What is Bionomics Limited's quote symbol?

(NASDAQ: BNOX) Bionomics Limited trades on the NASDAQ under the ticker symbol BNOX. Bionomics Limited stock quotes can also be displayed as NASDAQ: BNOX.

If you're new to stock investing, here's how to buy Bionomics Limited stock.

What is the 52 week high and low for Bionomics Limited (NASDAQ: BNOX)?

(NASDAQ: BNOX) Bionomics Limited's 52-week high was $6.41, and its 52-week low was $0.87. It is currently -85.6% from its 52-week high and 6.09% from its 52-week low.

How much is Bionomics Limited stock worth today?

(NASDAQ: BNOX) Bionomics Limited currently has 1,924,808,444 outstanding shares. With Bionomics Limited stock trading at $0.92 per share, the total value of Bionomics Limited stock (market capitalization) is $10.66M.

Bionomics Limited stock was originally listed at a price of $14.73 in Dec 16, 2021. If you had invested in Bionomics Limited stock at $14.73, your return over the last 2 years would have been -93.73%, for an annualized return of -74.97% (not including any dividends or dividend reinvestments).

How much is Bionomics Limited's stock price per share?

(NASDAQ: BNOX) Bionomics Limited stock price per share is $0.92 today (as of Apr 23, 2024).

What is Bionomics Limited's Market Cap?

(NASDAQ: BNOX) Bionomics Limited's market cap is $10.66M, as of Apr 24, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Bionomics Limited's market cap is calculated by multiplying BNOX's current stock price of $0.92 by BNOX's total outstanding shares of 1,924,808,444.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.